8-K: Ryan Specialty Reports Strong Q4 and Full Year 2024 Results, Driven by Organic Growth and Strategic Acquisitions

Ryan Specialty Holdings announces a 24.5% increase in Q4 revenue and a 21.1% increase in full-year revenue, fueled by organic growth and strategic M&A.

Summary

• Ryan Specialty Holdings, Inc. reported its fourth-quarter and full-year 2024 financial results.
• Total revenue for Q4 2024 grew by 24.5% year-over-year to $663.5 million, while full-year revenue increased by 21.1% to $2,515.7 million.
• The organic revenue growth rate was 11.0% for the quarter and 12.8% for the year.
• Net income for Q4 decreased by 27.3% to $42.6 million, but full-year net income increased by 18.2% to $229.9 million.
• Adjusted EBITDAC increased by 36.2% to $216.0 million for the quarter and by 29.8% to $811.2 million for the full year.
• The company's board declared a regular quarterly dividend of $0.12 per share, a 9.1% increase.
• Ryan Specialty is initiating its full-year 2025 outlook for organic revenue growth rate to be between 11.0% and 13.0% and adjusted EBITDAC margin to be between 32.5% and 33.5%.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results and growth projections, supported by strategic acquisitions and increased dividends. While there are some negative aspects, the overall tone is optimistic.

Positives

• Strong revenue growth driven by both organic expansion and strategic acquisitions.
• Significant increase in Adjusted EBITDAC and Adjusted diluted earnings per share.
• Successful execution of M&A strategy, adding substantial annualized revenue.
• Increased quarterly dividend, demonstrating confidence in future performance.
• Positive outlook for 2025 with continued organic revenue growth and strong adjusted EBITDAC margin expected.

Negatives

• Net income decreased by 27.3% in Q4 2024 compared to the prior-year period, primarily due to higher income tax expense and interest expense.
• Organic Revenue Growth Rate decreased from 16.5% in the prior-year period to 11.0% for the quarter.

Risks

• The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
• These risks include factors disclosed in the company's filings with the SEC, such as those related to restructuring initiatives, acquisitions, legal and regulatory matters, and changes in legislation or regulations.
• The company's inability to provide a comparable outlook for Total revenue growth rate or Net income margin is due to the inherent difficulty in forecasting the timing of items that have not yet occurred and quantifying certain amounts that are necessary for such reconciliation.

Future Outlook

The company anticipates an organic revenue growth rate between 11.0% and 13.0% and an adjusted EBITDAC margin between 32.5% and 33.5% for the full year 2025.

Management Comments

• Patrick G. Ryan, Founder and Executive Chairman, stated that 2024 was another outstanding year with 21% total revenue growth, supported by 12.8% organic growth and strong contributions from M&A.
• Tim Turner, Chief Executive Officer, highlighted the significant new business growth and strong renewal retention, coupled with significant M&A, which increased market share and expanded the total addressable market.
• Management believes they are well-positioned to deliver sustainable and differentiated growth in 2025 and over the long term.

Industry Context

Ryan Specialty's focus on specialty insurance products and solutions positions it well in a market where specialized expertise is increasingly valued. The company's growth through acquisitions aligns with the industry trend of consolidation to gain market share and expand capabilities.

Comparison to Industry Standards

• Comparing Ryan Specialty to peers like Brown & Brown, Inc. and Arthur J. Gallagher & Co., Ryan Specialty's organic growth rate of 12.8% for the year is competitive.
• The Adjusted EBITDAC margin of 32.2% is also strong compared to industry averages.
• The company's focus on specialty insurance aligns with a broader industry trend towards specialized services, similar to how companies like Amwins Group and CRC Group operate.

Stakeholder Impact

• Shareholders will benefit from the increased dividend and potential for future growth.
• Employees will have opportunities for career advancement within a growing company.
• Clients will have access to a wider range of specialized insurance solutions.
• Trading partners will benefit from the company's continued expansion and market leadership.

Next Steps

• The company will continue to execute its M&A strategy.
• Ryan Specialty will focus on delivering sustainable and differentiated growth in 2025 and beyond.
• The company will pay the increased quarterly dividend on March 18, 2025.

Key Dates

Keywords

Ryan Specialty, financial results, revenue growth, organic growth, acquisitions, EBITDAC, insurance, dividends